Ad
related to: amerisourcebergen abc nyseschwab.com has been visited by 100K+ users in the past month
- thinkorswim®
Access The Award-Winning Platform
Built By Traders, For Traders.
- Schwab Investing Themes™
Invest In Ideas You Believe In -
Choose From Over 40 Themes.
- Trader Education
Explore Our Education Library To
Get From "How?" to "Know-How."
- Pricing for Online Trades
No Account Fees or Platform Fees
With Schwab's Trading Services.
- thinkorswim®
Search results
Results from the WOW.Com Content Network
Financials as of September 30, 2023. [update] [1] Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale company and a contract research organization that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. [2]
For premium support please call: 800-290-4726 more ways to reach us
Let's see if AmerisourceBergen Corporation (ABC) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
AmerisourceBergen's (ABC) fiscal third-quarter results are likely to reflect solid performance at Pharmaceutical Distribution and Other units.
AmerisourceBergen (ABC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
AmerisourceBergen's (ABC) fiscal first-quarter results are likely to reflect solid performance at the U.S. Healthcare Solutions segment.
AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
AmerisourceBergen (ABC) possesses solid growth attributes, which could help it handily outperform the market. Is AmerisourceBergen (ABC) a Solid Growth Stock? 3 Reasons to Think "Yes" Skip to main ...
Ad
related to: amerisourcebergen abc nyseschwab.com has been visited by 100K+ users in the past month